Legal Funding Journal is dedicated to informing and engaging the global legal funding community through daily news, insight, analysis and original content.

Manolete Partners, the AIM-listed specialist in insolvency litigation finance, has reported a record year across several operational metrics for the twelve months ended March 31, 2026, even as realised revenue dipped and its share price slid. The funder, which finances claims pursued by insolvency practitioners in exchange for a share of recoveries, framed the results as the foundation for an ambitious next phase of growth.

As reported by Legal Futures, Manolete logged an all-time high of 1,027 case referrals, up 15%, and ended the year with 446 live cases and a forward book valued at £67 million — a 37% increase year-on-year. The proportion of larger claims grew, with cases expected to generate £500,000 or more accounting for £32 million of the forward book, up from £21 million. Average claim value rose to £158,000 from £124,000.

Realised revenue fell 6.5% to £28 million, but gross margin improved five percentage points to 37%, and a single truck-cartel settlement returned £3.2 million — a 560% return on the cash invested. Profit before tax margin remained thin at 0.4%.

Chief Executive Mena Halton, who took the role in August 2025, said the company "strengthened our team and new business development function to support the next phase of growth." Manolete set medium-term targets including realised revenue of £42 million and a 12% profit-before-tax margin, signaling confidence in the depth of the UK insolvency litigation market despite the stock's decline to 36p.

Australian companies face a class action landscape increasingly shaped by events beyond their borders, according to new analysis warning that overseas litigation, foreign regulatory activity, and global litigation funding flows now operate as leading indicators of claims that later emerge at home. For boards and executives, the message is that domestic precedent alone no longer defines exposure.

As reported by Corrs Chambers Westgarth, plaintiff firms are explicitly modeling Australian claims on foreign proceedings — in one instance announcing it was "investigating how an Australian claim could be run" following a U.S. technology ruling. The pattern spans medical products, automotive, and technology, with expansion anticipated into privacy, data, cyber, and climate-related disputes.

Foreign regulatory enforcement frequently acts as the catalyst. When overseas regulators scrutinize issues such as PFAS contamination or particular medications, Australian plaintiff firms often follow, leveraging the country's flexible consumer protection framework to build comparable claims.

Litigation funding plays a central role in this dynamic, with capital moving across jurisdictions to balance risk and return. The analysis notes that recent Australian court decisions — including rulings on common fund orders and confirmation of soft class closure — are expected to attract greater global funding capacity, potentially increasing both the volume and the resourcing of claims.

The practical takeaway for senior decision-makers is to monitor international developments proactively. Understanding overseas litigation strategies, regulatory priorities, and funding trends has become essential to anticipating exposure before Australian proceedings materialize.

The UK's Competition Appeal Tribunal has certified a £3 billion collective claim against Apple, allowing one of the country's largest consumer actions to proceed toward trial. The case, brought by consumer group Which?, alleges that Apple abused its dominant position in the iOS ecosystem by unlawfully favoring its own iCloud service over competing cloud storage providers.

As reported by The Global Legal Post, the tribunal certified the proceeding on June 25, 2026, sweeping in roughly 39 million UK consumers who used iCloud between November 2018 and June 2026. The opt-out structure means eligible UK residents are automatically included, while non-UK residents from the relevant period may opt in by October 8, 2026. Successful class members could recover up to £77 each, with trial scheduled for October 2028.

Which?, acting as class representative, has the backing of Litigation Capital Management's UK subsidiary, which is funding the claim. Notably, the tribunal dismissed Apple's objections to that funding arrangement — a point of continued significance as UK courts refine the rules governing third-party finance in the wake of the PACCAR decision.

Apple rejected the allegations, stating that it "rejected any suggestion that our iCloud practices are anti-competitive" and pointing to "plenty of alternatives to choose from." The certification marks another milestone for funder-backed collective actions in the UK, where well-capitalized consumer claims against major technology platforms continue to test the limits of competition law.

Pogust Goodhead has lined up fresh capital and elite co-counsel for the next phase of its landmark claim against mining giant BHP over the 2015 Mariana dam collapse in Brazil — one of the largest group actions ever brought in the English courts. The firm announced $150 million in new funding from Gramercy Funds Management, with an initial $85 million tranche, alongside a strategic partnership with U.S. litigation powerhouse Quinn Emanuel.

As reported by The Global Legal Post, Quinn Emanuel will join as co-counsel for the quantum phase of proceedings, led by partner Justin Michelson and beginning in October 2026. The injection of funding and firepower comes as the case shifts from establishing liability to determining how much BHP must pay claimants.

The litigation has already cleared significant hurdles. In November 2025, Justice O'Farrell ruled BHP "strictly liable" for the Fundão dam failure, and the Court of Appeal rejected BHP's bid to challenge that finding in March 2026. Pogust Goodhead has secured an interim costs award of roughly £43 million, with claimants awarded 90% of their Stage 1 costs.

The road ahead remains long. The Stage 1 quantum trial is set for October 2026, with further proceedings on causation, loss, and damages scheduled across 2027 and closing submissions expected in March 2028. Damages assessments could extend well beyond 2030, underscoring both the scale of the claim and the staying power that third-party capital provides.

Omni Bridgeway, one of the world's largest legal finance providers, has released new content underscoring the specialized expertise required to fund international arbitration — disputes that frequently span multiple jurisdictions, legal systems, and languages. The piece positions the funder's cross-border capabilities as central to navigating an increasingly complex global disputes market.

According to Omni Bridgeway, funding international arbitration effectively demands a combination of "global expertise and local knowledge." The firm — listed on the ASX with 24 offices worldwide — points to a team that includes former arbitration lawyers and litigators, arbitrators, leaders of arbitral institutions, and business users of arbitration as the basis for its claim to be a global leader in the space.

The content emphasizes capabilities that distinguish arbitration finance from domestic litigation funding: risk assessment across multiple jurisdictions, cultural and multilingual fluency, and access to worldwide professional networks. Each reflects the reality that an arbitration award secured in one forum may still require enforcement efforts in several others before a funder or claimant sees a return.

While the material is promotional in nature, it reflects a broader trend: rising demand for capital and risk-sharing in cross-border disputes as international arbitration continues to grow. For claimants weighing whether to pursue complex multinational claims, the involvement of specialized funders increasingly shapes which cases move forward — and how far they can be pressed.

A court filing in the bankruptcy of Montgomery-based Jackson Hospital reveals that, under a joint prosecution and funding agreement, litigation funders and lawyers would be paid ahead of the hospital itself if its lawsuit against Blue Cross and Blue Shield of Alabama produces a settlement. The arrangement offers an unusually clear public window into how a funded litigation recovery can be distributed.

As reported by Alabama Daily News, Jackson Hospital filed for bankruptcy and sued Blue Cross, arguing that only higher insurance reimbursement rates can keep the facility open. Its current operations are financed through a debtor-in-possession loan from Jackson Investment Group (JIG).

According to the agreement, any settlement proceeds would follow a strict waterfall: first, JIG's legal expenses; second, repayment of JIG's investment, including accrued and unpaid interest; and only then a split of what remains, with 70% directed to Jackson Hospital Corporation for its obligations to JIG and 30% to a nonprofit of JIG's choosing. The hospital itself effectively ranks third in the payment hierarchy.

The structure highlights a recurring tension in litigation finance: a courtroom victory does not always translate into the outcome a funded party most needs — here, the survival of the hospital. U.S. Bankruptcy Judge Christopher Hawkins has scheduled a status hearing for June 30, leaving the ultimate distribution, and the hospital's future, unresolved.

As New York's new consumer litigation lending law takes effect, a Buffalo-based nonprofit is positioning itself as an alternative to the traditional, for-profit funding model the legislation is designed to rein in. The Milestone Foundation, backed by a newly formed advisory council and a client base of roughly 1,000, says its approach is built around reshaping how plaintiffs access funds while their cases are pending.

As reported by Law.com, the foundation is seeking to differentiate itself from conventional consumer litigation lenders, which advance cash to plaintiffs in personal injury and other cases in exchange for a share of any eventual recovery. Critics of that model have long argued that compounding fees can consume an outsized portion of a plaintiff's award, a concern that helped drive New York's move toward tighter regulation.

The timing is notable. New York's law arrives amid a broader national reckoning over consumer legal funding, with several states weighing disclosure requirements, rate caps, and other guardrails on the practice. By advancing a nonprofit alternative as the regulatory landscape shifts, the Milestone Foundation is testing whether a mission-driven structure can coexist with — and compete against — established commercial funders.

The development underscores how regulation and market innovation are increasingly moving in tandem within consumer legal funding. For plaintiffs, lawyers, and funders alike, New York's experience may offer an early indication of how alternative models perform once stricter rules are in place.

A new comment letter to the Advisory Committee on Civil Rules contends that third-party litigation funding (TPLF) agreements do not automatically qualify for protection under the attorney-client privilege or the work-product doctrine — directly challenging one of the funding industry's central objections to a federal rule mandating disclosure.

According to AskAboutTPLF, an initiative of Lawyers for Civil Justice, the letter was authored by Bradley partner and privilege specialist Todd Presnell, who takes no position on whether a disclosure rule should be adopted. Presnell argues that TPLF agreements fail all four requirements needed to trigger attorney-client privilege: they are not communications, they are not between a client and lawyer, they lack confidentiality because funders are not parties to the litigation, and they do not contain legal advice or strategy. On that basis, he writes that he does "not perceive the attorney-client privilege or work-product doctrine as a barrier to adopting a mandatory-disclosure rule."

Two recent rulings are cited as support. In *Entangled Media, LLC v. Dropbox Inc.* (N.D. Cal., April 13, 2026), a court permitted a funded plaintiff to seal specific financial terms after in camera review while ordering production of the remainder of the agreement. In *A Co. Hungary KFT v. Bespalov* (Cal. App. 2d Dist., April 22, 2026), an appellate court affirmed $8,000 in sanctions against a judgment debtor who asserted work-product privilege as a blanket objection, holding that privilege claims over funding records must be made document by document.

The campaign argues these cases show courts already redact, seal, and log privileged materials routinely, and that TPLF agreements require no different treatment.

North Carolina has become the first state in the nation to enact an outright ban on third-party litigation funding, after Governor Josh Stein signed House Bill 315 into law. The measure makes it unlawful for outside investors to finance civil lawsuits in exchange for a financial interest tied to the outcome of the case, marking a significant departure from the disclosure-and-transparency approach adopted by other states.

As reported by WWAY-TV3, the law defines litigation investment as providing money for the fees, costs, or expenses of pending or potential civil proceedings in return for compensation contingent on the result. The statute authorizes the state attorney general to seek injunctions and civil penalties against violators, though certain activities are carved out from the prohibition.

The bill drew broad legislative support, passing the House unanimously and clearing the Senate by a 45-1 margin. Business groups, including the North Carolina Chamber and the U.S. Chamber of Commerce's Institute for Legal Reform, backed the measure, arguing it strengthens the state's legal and business climate. Critics counter that third-party funding can expand access to the courts for parties who otherwise lack the resources to pursue meritorious claims.

The development represents a notable escalation in the regulatory debate over litigation finance in the United States. While states such as Ohio and others have advanced transparency requirements, North Carolina's outright prohibition sets a new precedent that funders, defense interests, and legislators in other jurisdictions are likely to watch closely.